STJ  St. Jude Medical Inc.

Exchange

NYSE

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.

20.75B

Vuru Grade

66.32/100

Current Price

$73.80
-0.35 (-0.47%)

Growth Price

$54.24
Overvalued by 26.50%

Stability Price

$20.60
Overvalued by 72.09%

Company Metrics

  • 21.03 P/E
  • 3.72 P/S
  • 5.41 P/B
  • 3.51 EPS
  • 14.54% Cash ROIC
  • 0.54 Cash Ratio
  • 1.16 / 1.60 % Dividend
  • 1.76M Avg. Vol.
  • 281.17M Shares
  • 20.75B Market Cap.

Company Description

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

St. Jude Medical (STJ) Stock Coverage Initiated at Evercore ISI
TheStreet.com - May 27, 2015
"We rate ST JUDE MEDICAL INC (STJ) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate.
St. Jude Medical Research Coverage Started at Evercore ISI (STJ) - sleekmoney
Insider Deal: St. Jude Medical, Inc. (NYSE:STJ)'s director Barbara Hill Sold ...
OctaFinance.com - May 6, 2015
St. Jude Medical, Inc. (NYSE:STJ) 74.27 -0.47 -0.63% director and an insider Barbara Hill a few days ago sold 3,229 company shares having a total value $229,711 at an avg stock price per share of $71.1.
St. Jude Medical Announces Dividend for Second Quarter of Fiscal Year 2015 - MarketWatch
St. Jude Medical (STJ) MRI-Compatible Devices CE Marked
Zacks.com - May 14, 2015
St. Jude Medical Inc. (STJ - Analyst Report) recently announced the receipt of CE Mark approval for expanded labeling of its Ellipse implantable cardioverter defibrillator (ICD) in Europe.
St. Jude Medical Expands Portfolio Of MRI-Compatible Devices To High Voltage ... - Med Device Online (press release)
St. Jude Medical Presents Positive Data from ILUMIEN Trials
Zacks.com - May 21, 2015
St. Jude Medical, Inc. (STJ - Analyst Report) recently presented data from two trials which jointly prove that its optical coherence tomography (OCT) imaging can guide better stent implantation in patients with coronary artery disease.
New Data Further Emphasize the Clinical Benefits of St. Jude Medical's OCT ... - Anadolu Agency
St. Jude Medical Presents Data on Quadripolar Technology
Zacks.com - May 15, 2015
Presented at the session was data from a study which was conducted to compare St. Jude Medical's Quartet LV lead with a standard bipolar pacing lead.
Data Shows Improved Outcomes for Patients With St. Jude Medical Quadripolar ... - MarketWatch
St. Jude Medical, Inc. (NYSE:STJ) Sees Large Outflow of Money
Money Flow Index - May 28, 2015
St. Jude Medical, Inc. (NYSE:STJ) traded on a positive note gaining 0.33 points or 0.45% to be valued at $74.02 per share.
St. Jude Medical Earns Hold Rating from Analysts at Evercore ISI (STJ) - Mideast Time
St. Jude Medical Announces Canadian Launch and First Implant of the Prodigy ...
Business Wire (press release) - May 19, 2015
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced Health Canada approval and first implant in Canada of its Prodigy™ Chronic Pain System with Burst technology.
Analyst Views: St. Jude Medical, Inc. (NYSE:STJ)
Markets Daily - May 12, 2015
Based on analyst estimates, St. Jude Medical, Inc. (NYSE:STJ) is expected to post current fiscal quarter earnings per share of $0.99.
Inexpensive St. Jude Medical Keeps Rewarding Shareholders (STJ) - Seeking Alpha
Stock in Focus - St. Jude Medical, Inc. (NYSE:STJ) - Vanguard Tribune
Stocks Taking Sector High- STMicroelectronics NV (NYSE:STM), St. Jude ...
StreetWise Report - May 21, 2015
St. Jude Medical Inc. (NYSE:STJ) reported that preliminary results from the ILUMIEN I trial as well as final results from the ILUMIEN II clinical study.
St. Jude Medical Completes Acquisition Of Spinal Modulation, Inc.
Med Device Online (press release) - May 5, 2015
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced it has completed the acquisition of Spinal Modulation, Inc., developer of the Axium™ Neurostimulator System.